LOL quote, "Then you don't know about Bluebird Bio and when institutions started buying it. Check it out."
Who doesn't know about Bluebird Bio???
1) It's a Nasdaq listed stock it was NEVER a straight to OTC penny stock, ever. From its beginning it was backed by a who's who of highest quality venture/risk capital investors
2) It has over $300 MILLION in cold, hard cash with ZERO debt
3) It has revenues of $25 million annual
4) They are partnered with a powerhouse CELGENE
And those are just the small points. To try and lump this in as some "case study" of institutional ownership versus OCAT, a penny stock for all intents and purposed (and a broke one at that) - is comparing apples to asparagus.
No linkage between the two at all. None.
Posts contain only my amateur opinions, personal views and thoughts. I discuss stocks as a hobby only. Always do one's own due diligence before investing.